image dons

I make a donation

ATLANTIS

Demonstrate the superiority of an anticoagulation strategy with Apixaban compared with a standard treatment in patients having had a TAVI

Terminée

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

Bourses ACTION & PHRA 2022

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Prix de Recherche Pr Jean-Philippe COLLET

logo étude

objectif

Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis

date de réalisation

2016

nombre de patients

1510

nombre de centres participants

International multicentric trial

type de financement

Private (BMS & Pfizer)

Référence

NCT02664649

A study conducted by Fonds de Dotation ACTION
Find out details and results on the dedicated page

ATLANTIS conducted by Fonds de Dotation ACTION

Autres études

+

AFIJI

En cours

Impact of genetics on occuring of coronary diseases in young patients and the pharmacogenetic of clopidogrel and its impact on the prognosis of patients having had angioplasty
Lire la suite
+

BIO-TAVI

En cours

Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI
Lire la suite
+

AMUNDSEN

En cours

A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....
Lire la suite